Benefit-Risk Assessment of Medication : A Case Study of HMG-CoA reductase inhibitors (Statins)
Full Metadata
| Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Surachat Ngorsuraches | - |
| dc.contributor.author | Tanatape Wanishayakorn | - |
| dc.contributor.department | Faculty of Pharmaceutical Sciences (Pharmacy Administration) | - |
| dc.contributor.department | คณะเภสัชศาสตร์ ภาควิชาบริหารเภสัชกิจ | - |
| dc.date.accessioned | 2017-04-07T08:17:43Z | - |
| dc.date.available | 2017-04-07T08:17:43Z | - |
| dc.date.issued | 2015 | - |
| dc.description | Thesis (Ph.D.Pharm., (Social and Administrative Pharmacy))--Prince of Songkla University, 2015 | th_TH |
| dc.identifier.uri | http://kb.psu.ac.th/psukb/handle/2016/10738 | - |
| dc.language.iso | en | th_TH |
| dc.publisher | Prince of Songkla University | th_TH |
| dc.subject | Drugs risk | th_TH |
| dc.title | Benefit-Risk Assessment of Medication : A Case Study of HMG-CoA reductase inhibitors (Statins) | th_TH |
| dc.title.alternative | การประเมินประโยชน์และความเสี่ยงของยา : กรณีศึกษายากลุ่ม HMG-CoA reductase inhibitors (Statins) | th_TH |
| dc.type | Thesis | th_TH |
Files
Collections